Maxigen Biotech Inc. (TPE:1783)

Maxigen Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	792.49	680.65	622.12	604.43	511.98	457.69
Revenue	792.49	680.65	622.12	604.43	511.98	457.69
Revenue Growth (YoY)	27.05%	9.41%	2.93%	18.06%	11.86%	1.21%
Cost of Revenue	243.05	197.33	198.02	230.44	250.95	243.17
Gross Profit	549.45	483.33	424.09	373.99	261.03	214.52
Selling, General & Admin	188.72	176.98	205.45	141.03	92.38	84.36
Research & Development	126.67	111.97	68.6	99.63	75.68	69.15
Operating Expenses	310.65	303.42	274.24	245.38	171.08	153.42
Operating Income	238.8	179.91	149.85	128.62	89.95	61.11
Interest Expense	-	-	-	-0.07	-0.2	-0.25
Interest & Investment Income	34.5	27.43	25.02	3.18	0.48	0.78
Currency Exchange Gain (Loss)	-3.45	17.14	4	31.69	-3.6	-5.52
Other Non Operating Income (Expenses)	1.67	1.05	0.66	1.08	10.84	20.62
EBT Excluding Unusual Items	271.52	225.53	179.53	164.5	97.47	76.74
Gain (Loss) on Sale of Investments	-	0.02	-	-	-	-
Gain (Loss) on Sale of Assets	-	-0	13.62	1.03	-	-
Other Unusual Items	-	-	-	0.26	-	-
Pretax Income	271.52	225.55	193.14	165.78	97.47	76.74
Income Tax Expense	37.45	35.38	27.31	26.38	9.8	13.43
Net Income	234.07	190.17	165.83	139.4	87.67	63.31
Net Income to Common	234.07	190.17	165.83	139.4	87.67	63.31
Net Income Growth	50.69%	14.68%	18.95%	59.01%	38.47%	5.32%
Shares Outstanding (Basic)	90	89	89	89	84	80
Shares Outstanding (Diluted)	90	90	89	89	85	81
Shares Change (YoY)	0.62%	0.27%	0.07%	5.78%	4.81%	-8.21%
EPS (Basic)	2.61	2.13	1.86	1.57	1.04	0.79
EPS (Diluted)	2.59	2.12	1.85	1.56	1.04	0.79
EPS Growth	49.65%	14.59%	18.59%	50.28%	31.75%	10.53%
Free Cash Flow	223.54	266.45	148.76	254.05	103.34	63.82
Free Cash Flow Per Share	2.48	2.97	1.66	2.84	1.22	0.79
Dividend Per Share	0.830	0.830	1.000	0.476	-	0.632
Dividend Growth	-17.00%	-17.00%	110.00%	-	-	-6.41%
Gross Margin	69.33%	71.01%	68.17%	61.88%	50.98%	46.87%
Operating Margin	30.13%	26.43%	24.09%	21.28%	17.57%	13.35%
Profit Margin	29.54%	27.94%	26.66%	23.06%	17.12%	13.83%
Free Cash Flow Margin	28.21%	39.15%	23.91%	42.03%	20.18%	13.94%
EBITDA	268.38	206.75	177.09	156.71	119.73	91.22
EBITDA Margin	33.87%	30.38%	28.47%	25.93%	23.39%	19.93%
D&A For EBITDA	29.58	26.85	27.24	28.09	29.79	30.11
EBIT	238.8	179.91	149.85	128.62	89.95	61.11
EBIT Margin	30.13%	26.43%	24.09%	21.28%	17.57%	13.35%
Effective Tax Rate	13.79%	15.69%	14.14%	15.91%	10.05%	17.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.